We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
NexMed, Inc., a developer of innovative treatments based on the NexACT drug delivery technology, has announced that it has received a Notice of Allowance from the U.S. Patent & Trademark Office for its U.S. patent application entitled, "Prostaglandin Compositions & Methods of Treatment for Male Erectile Dysfunction.
Mutual Pharmaceutical Company/AR Scientific announced the commercial introduction of QUALAQUIN (quinine sulfate capsules USP, 324 mg) for the treatment of uncomplicated Plasmodium falciparum malaria.
Invitrogen Corporation and the Human Proteome Organisation (HUPO) have entered a scientific collaboration focused on advancing proteomic research through education initiatives, standardization
of research protocols and development of advanced proteomic products.
Healthcare services provider Cardinal Health Inc. said Wednesday that it plans to acquire privately-held medical analytics firm MedMined Inc. for an undisclosed amount.
Glaxosmithkline plc, a research-based pharmaceutical and healthcare company, said on Wednesday data from the first two studies published in Vaccine showed that GSK's cervical cancer candidate vaccine formulated with the AS04 adjuvant system not only evoked higher and more sustained antibody levels but also stronger immune memory response.
Boehringer Ingelheim and the FDA have announced updates to the black box warning for Aptivus, a treatment for HIV, after it was linked to multiple fatal cases of brain hemorrhaging.
Rising prescription drug costs, especially for the uninsured, point to the need for a more vibrant generic drug market and more active state price negotiations, an activist group concluded in a recent report.
Solvay Pharmaceuticals, Inc. announced today that it has settled a lawsuit filed against Global Pharmaceuticals and Impax Laboratories, Inc. alleging that the companies falsely advertised and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' CREON MINIMICROSPHERES (Pancrelipase Delayed-release Capsules, USP).